Mobile-health Network Solutions addresses recent share price fluctuations, reaffirms long-term commitment

May 6, 2024 by No Comments

SINGAPORE, May 06, 2024 — Mobile-health Network Solutions (Nasdaq: MNDR) (“MaNaDr” or “the Company”), a leading Asia-Pacific telehealth provider, today addresses recent market fluctuations in its share price with a message from Co-Founders Dr Siaw Tung Yeng and Dr Rachel Teoh Pui Pui.

Dear Valued Shareholders, Investors, Employees, and Partners, we are writing today to address recent volatility in our share price. While we understand the concern it may cause, we want to assure you that we remain committed to our long-term growth strategy, and we are experiencing significant positive developments.

Mobile-health Network Solutions is currently in the process of expanding our operations to Indonesia, a key market in Southeast Asia, offering substantial growth potential. This expansion aligns with our strategic vision and will further solidify our presence in the region. We were recently recognized by the Financial Times as the #41 fastest growing company in the Asia-Pacific region (APAC). This prestigious accolade is a testament to the hard work and dedication of our team and reflects the strong trajectory of our business.

We announced the launch of ManaPharma Pharmacy recently, representing a venture into the retail pharmacy space. This diversification strengthens our position in the healthcare sector and presents promising opportunities for future growth.

As outlined in our 424B(4) prospectus, our management remains focused on executing our established strategies and priorities. We are confident that this continued focus will drive long-term value for all stakeholders.

Our management and our major shareholders are committed to the long-term success of the Company. We have a moratorium in place and have not sold or pledged any shares for loans since the IPO.

We are optimistic about our financial performance. As announced recently, our revenue for the first half of 2024 is projected to double compared to the same period in 2023. This significant growth underscores the effectiveness of our strategic initiatives.

Considering the recent share price fluctuations, we have reached out to Nasdaq to request discussions regarding the trading activities.

We are committed to maintaining open communication with all stakeholders. We will continue to provide regular updates on our progress and performance through official channels.

We understand that market conditions can be unpredictable, however, we remain confident in the fundamentals of our business and believe that MNDR is well positioned for continued success. We appreciate your continued support and trust.

Co-Founder, Dr Siaw Tung Yeng, PBM, Senior Consultant Family Physician
Co-Founder, Dr Rachel Teoh Pui Pui, PBM, Family Physician